# Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery

> **NCT01451788** · PHASE4 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Adolescent Idiopathic Scoliosis

## Interventions

- **DEVICE:** Gelatin matrix with human derived thrombin (Floseal, Baxter)

## Key facts

- **NCT ID:** NCT01451788
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2014-12
- **Final completion:** 2016-12
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-10-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01451788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01451788, "Effect of Human Thrombin With Gelatin Matrix on Perioperative Blood Loss in Scoliosis Surgery". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01451788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*